'Why always me?' is the song on the lips of Serena Williams who is no longer finding it funny as she claims she is being subjected to more frequent doping tests compared to her peers

Williams sees nothing “random” with how the U.S. Anti-Doping Agency conducts its business.

The tennis star recently advanced all the way to the Wimbledon finals before falling to Angelique Kerber, an impressive achievement considering she gave birth to a baby girl less than a year ago.

But that achievement may have caught the eye of the USADA, which, according to Williams, “randomly” selected her for another drug test Tuesday.

Suffice it to say, Williams wasn’t happy with this development.

Indeed, Serena is not raising a false as alarm as check on the regulatory agency reveals that the last three Grand Slam winners — Kerber, Simona Halep (French Open) and Caroline Wozniacki (Australian Open) — have yet to be tested this year.

Even Maria Sharapova, who received a two-year ban from the sport for using an illegal substance, has no drug tests on record with the USADA.

The last Grand Slam winner to take at least one drug test was Sloane Stephens, who won the 2017 U.S. Open and submitted to three drug tests in the calendar year of 2017.

Williams also took three drug tests that year, as did her sister, Venus Williams, who was tabbed for two more “random” drug tests in 2018.

Don’t forget to share this article with your friends and family.